Epocrates Drug Updates — Editor’s Pick
May 7, 2008
New Drug Monograph for Pristiq
The FDA has approved Pristiq (desvenlafaxine), the major active metabolite of venlafaxine, for the treatment of major depressive disorder in adults.
New Drug Monograph for Pristiq
Recent Updates
- April 30, 2008
- New Drug Monograph for Fenoglide
The FDA has approved Fenoglide (fenofibrate) for the treatment of hyperlipidemia, mixed dyslipidemia, or hypertriglyceridemia. Review Monograph for Fenoglide » - April 23, 2008
- Pediatric Indication for Reyataz
The FDA has approved Reyataz (atazanavir) for the treatment of HIV infection in patients 6-17 years of age. Review Monograph for Reyataz - April 16, 2008
- Additional Indication for Aloxi
The FDA has approved Aloxi (palonosetron) for the prevention of postoperative nausea and vomiting for up to 24 hours following surgery. Review Monograph for Aloxi »
New Drug Monographs
RSS Feed
Top drug searchesThese updates, and hundreds more, are available in all Epocrates mobile and online products. See Products
To update your mobile reference, simply AutoUpdate (sync). Learn How